CureVac N.V. (CVAC)
NASDAQ: CVAC · IEX Real-Time Price · USD
3.720
+0.080 (2.20%)
At close: Jul 26, 2024, 4:00 PM
3.760
+0.040 (1.08%)
After-hours: Jul 26, 2024, 6:49 PM EDT
CureVac Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 59 | 53.76 | 67.42 | 102.99 | 48.87 | 17.42 | Upgrade
|
| Revenue Growth (YoY) | 17.59% | -20.26% | -34.54% | 110.74% | 180.61% | 35.31% | Upgrade
|
| Cost of Revenue | 137.27 | 116.21 | 158.97 | 215.27 | 14.17 | 27.98 | Upgrade
|
| Gross Profit | -78.27 | -62.45 | -91.55 | -112.28 | 34.7 | -10.57 | Upgrade
|
| Selling, General & Admin | 91.71 | 95.74 | 107.07 | 102.26 | 54.29 | 50.72 | Upgrade
|
| Research & Development | 119.3 | 115.72 | 62.55 | 815.91 | 113.81 | 43.24 | Upgrade
|
| Other Operating Expenses | -2.64 | -2.17 | -34.83 | -0.1 | 0.15 | 0.35 | Upgrade
|
| Operating Expenses | 208.36 | 209.29 | 134.8 | 918.07 | 168.25 | 94.32 | Upgrade
|
| Operating Income | -286.62 | -271.74 | -226.34 | -1,030.35 | -133.55 | -104.88 | Upgrade
|
| Interest Expense | - | - | -2.3 | -6.79 | -22.1 | -1.46 | Upgrade
|
| Interest & Investment Income | 15.91 | 15.41 | 1.73 | 0.08 | 2.07 | 0.83 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.21 | -1.21 | 0.87 | 6.15 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.04 | 0.04 | -0 | 0.32 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -271.89 | -257.51 | -226.04 | -1,030.58 | -153.58 | -105.51 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.11 | 1.2 | 0.79 | - | - | - | Upgrade
|
| Asset Writedown | -8.09 | -8.09 | -24.95 | -22.81 | - | - | Upgrade
|
| Other Unusual Items | 5.57 | 3.57 | 0.44 | 640.9 | 23.74 | 5.39 | Upgrade
|
| Pretax Income | -272.44 | -259.97 | -249.16 | -412.5 | -129.85 | -100.13 | Upgrade
|
| Income Tax Expense | 0.86 | 0.2 | -0.13 | -0.78 | -0.73 | -0.25 | Upgrade
|
| Net Income | -273.3 | -260.17 | -249.03 | -411.72 | -129.12 | -99.87 | Upgrade
|
| Net Income to Common | -273.3 | -260.17 | -249.03 | -411.72 | -129.12 | -99.87 | Upgrade
|
| Shares Outstanding (Basic) | 224 | 221 | 189 | 186 | 132 | 97 | Upgrade
|
| Shares Outstanding (Diluted) | 224 | 221 | 189 | 186 | 132 | 97 | Upgrade
|
| Shares Change (YoY) | 14.61% | 16.80% | 1.65% | 40.71% | 36.72% | - | Upgrade
|
| EPS (Basic) | -1.22 | -1.18 | -1.32 | -2.21 | -0.98 | -1.03 | Upgrade
|
| EPS (Diluted) | -1.22 | -1.18 | -1.32 | -2.21 | -0.98 | -1.03 | Upgrade
|
| Free Cash Flow | -309.22 | -320.21 | -374.2 | -857.35 | 486.07 | -98.14 | Upgrade
|
| Free Cash Flow Per Share | -1.38 | -1.45 | -1.98 | -4.61 | 3.68 | -1.01 | Upgrade
|
| Gross Margin | -132.65% | -116.17% | -135.79% | -109.02% | 71.00% | -60.67% | Upgrade
|
| Operating Margin | -485.79% | -505.49% | -335.72% | -1000.44% | -273.27% | -602.22% | Upgrade
|
| Profit Margin | - | - | - | - | -264.21% | - | Upgrade
|
| Free Cash Flow Margin | -524.09% | -595.65% | -555.03% | -832.46% | 994.61% | -563.48% | Upgrade
|
| EBITDA | -270.82 | -254.95 | -209.39 | -1,020.04 | -123.1 | -97.72 | Upgrade
|
| EBITDA Margin | - | - | - | - | -251.88% | - | Upgrade
|
| D&A For EBITDA | 15.81 | 16.79 | 16.96 | 10.31 | 10.46 | 7.16 | Upgrade
|
| EBIT | -286.62 | -271.74 | -226.34 | -1,030.35 | -133.55 | -104.88 | Upgrade
|
| EBIT Margin | - | - | - | - | -273.27% | - | Upgrade
|
Source: S&P Capital IQ. Standard template.